Literature DB >> 15509216

Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome.

Hyun-Young Son1, Seung-Won Ra, Jin-Ook Jeong, Eun-Hee Koh, Hyang-Im Lee, Jung-Min Koh, Won-Bae Kim, Joong-Yeol Park, Young-Kee Shong, Ki-Up Lee, Ghi-Su Kim, Min-Seon Kim.   

Abstract

Carcinoid tumors derived from neuroendocrine cells can release serotonin and other vasoactive substances into the systemic circulation, resulting in carcinoid syndrome. Testicular carcinoid, a rare disease accounting for less than 1% of all testicular neoplasms, rarely manifests symptoms of carcinoid syndrome. We describe a case of carcinoid syndrome arising from a primary testicular carcinoid tumor. A 21-year-old male patient presented with facial flushing and diarrhea for 5 years. He had an enlarged left testis and a 1-cm, ill-defined, hard, non-tender mass in his right testis. His 24 h urinary excretion of 5-hydroxyindoleacetic acid was elevated (16.1 mg/day). Somatostatin receptor scintigraphy correlated with carcinoid tumor in both testes. Following bilateral orchiectomy, the patient's facial flushing and diarrhea disappeared.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509216     DOI: 10.1111/j.1442-2042.2004.00925.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Primary pure carcinoid tumors of the testis: Clinicopathological and immunophenotypical characteristics of 11 cases.

Authors:  Changli Lu; Zhang Zhang; Yong Jiang; Zhirong Yang; Qunpei Yang; Dianying Liao; Hong Bu
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

Review 2.  Neuroendocrine Testicular Tumors: A Systematic Review and Meta-Analysis.

Authors:  Mseddi M Amine; Bouzguenda Mohamed; Hadjslimane Mourad; Hamza Majed; Charfi Slim; Bouassida Mehdi; Mnif Hela; Rebai Nouri; Kallel Rim; Boudaouara Tahya; Mhiri M Nabil
Journal:  Curr Urol       Date:  2017-03-30

3.  Successful management of an asymptomatic bilateral synchronous testicular carcinoid tumor with a testicular-sparing surgery.

Authors:  Lucio Dell'Atti
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.